CHARLOTTE, N.C. / Apr 02, 2025 / Business Wire / Premier, Inc. (NASDAQ: PINC), today announced the nation’s 100 Top Hospitals® with the full list of recognized hospitals published in Fortune®.
To create the list, an objective, quantitative analysis of publicly available data was conducted to identify the top hospitals in the United States. The primary purpose of Premier’s 100 Top Hospitals® program is to inspire hospital and health system leaders to pursue higher performance and deliver added value to patients and communities. The program also provides all hospitals a custom performance report free of charge that reviews their performance in comparison to peer hospitals and the identified top hospitals. Participation in the study is not application-based, and award winners do not pay to market their honor.
The Performance of Facilities on Premier’s 100 Top Hospitals Program® List
This year’s analysis compared the study’s top performing hospitals to a peer group of similar hospitals and found that Premier’s 100 Top Hospitals® delivered better outcomes while operating more efficiently. Compared to their peers, this year’s top performers achieved:
These outcomes add up to meaningful differences. According to the study’s analysis, if all hospitals operated at the level of this year’s top performers, more than 331,000 additional lives could have been saved, over 611,000 additional patients could have been complication-free and more than $15.1 billion in inpatient costs could have been saved for the 2025 study year.
This analysis is based on Medicare patients included in this study. If the same standards were applied to all inpatients, the impact could have been even greater.
“Premier’s 100 Top Hospitals® program recognizes the dedication of our nation’s top hospitals to consistently deliver high-quality care while working to continuously improve quality, patient experience and operational efficiency,” said David Zito, Premier’s President of Performance Services. “The program’s transparent, non-biased and actionable data helps set critical benchmarks for hospitals nationwide and enables leaders to make data-driven decisions that benefit patients and the health of communities we serve.”
Everest Award
17 facilities received the Everest Award, which recognizes hospitals that set national benchmarks for both the fastest rate of improvement and highest current year performance on Premier’s 100 Top Hospitals® balanced scorecard. This award recognizes the boards, executives and medical staff leaders who developed and executed strategies that helped drive the highest rates of improvement, resulting in the highest performance in the U.S. at the end of five years.
“We’re proud of the hospitals that achieved the Everest Award designation,” said Zito. “This recognition highlights their expertise and commitment to exceptional patient care while optimizing clinical, financial and operational improvements.”
Rankings Methodology
Premier’s 100 Top Hospitals® program focuses on short-term, acute care, non-federal U.S. hospitals that treat a broad spectrum of patients. Researchers evaluated 2,599 short-term, acute care, non-federal U.S. hospitals and health systems. All research was based on the following public data sets: Medicare cost reports, Medicare Provider Analysis and Review (MEDPAR) data, and data from the Centers for Medicare & Medicaid Services (CMS) Care Compare website. For complete methodology details, please review the study here.
Eligible hospitals are ranked for performance across nine measures within five domains.
Final rank is determined based on performance for all individual measures. To allow for fair comparison, hospitals are stratified and then ranked within five separate peer groups with a pre-determined number of high-performing hospitals: major teaching hospitals (20 facilities), teaching hospitals (20 facilities), large community hospitals (20 facilities), medium community hospitals (20 facilities) and small community hospitals (20 facilities).
Methodology for Selecting Everest Award Recipients within Premier’s 100 Top Hospitals® List
The methodology for selecting Everest Award recipients can be summarized in three main steps:
This methodology yields a select group of Everest Award Designation recipients. The number of top performers will vary every year, based solely on performance.
About Fortune
Fortune is a global multi-platform media company built on a legacy of trusted, award-winning reporting and information for those who want to make business better. Independently owned, Fortune tells the stories of the world's biggest companies and their leaders as well as a new generation of innovators who are moving business forward. Digitally and in print, Fortune measures corporate performance through rigorous benchmarks, and holds companies accountable, in regions around the world. Its iconic rankings include Fortune 500, Fortune Global 500, Most Powerful Women, and World's Most Admired Companies. Fortune builds world-class communities by convening industry thought leaders for exclusive summits and conferences, including the Fortune Global Forum, Brainstorm Tech, and Fortune Most Powerful Women. For more information, visit fortune.com.
About Premier
Premier, Inc. (NASDAQ: PINC) is a leading technology-driven healthcare improvement company, providing solutions to two-thirds of all healthcare providers in the U.S. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers, payers and policymakers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. Headquartered in Charlotte, N.C., Premier offers integrated data and analytics, collaboratives, supply chain solutions, consulting and other services in service of our mission to improve the health of communities. Please visit Premier’s news and investor sites on www.premierinc.com; as well as X, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.
Premier, Inc. Forward-Looking Statements
Statements made in this release that are not statements of historical or current facts, including but not limited to those related to Premier’s ability to advance its business strategies and improve healthcare, and the intended or expected performance or utility of Premier’s products and services, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties, and other factors that may cause performance or achievements to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risks and uncertainties relating to Premier and its products and services is included from time to time in the “Cautionary Note Regarding Forward-Looking Statements,” “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of Premier’s periodic and current filings with the SEC, which are also made available on Premier’s website at investors.premierinc.com. Forward-looking statements speak only as of the date they are made, and Premier undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events that occur after that date, or otherwise.
Last Trade: | US$19.33 |
Daily Change: | 0.01 0.05 |
Daily Volume: | 712,727 |
Market Cap: | US$1.860B |
February 04, 2025 December 03, 2024 November 05, 2024 August 19, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load